Browsing by Subject "Palbociclib"
Now showing items 1-2 of 2
-
Impact of the Latest Clinical Data among Patients with Breast Cancer in Low- and Middle-Income Countries
(2022-12)Introduction: In June 2022, experts from the oncology world gathered in Chicago, Illinois, for the American Society of Clinical Oncology (ASCO) 2022 annual meeting. In this article, we review the latest advancements ... -
Palbociclib releases the latent differentiation capacity of neuroblastoma cells
(2023)Abstract: Neuroblastoma is the most common extracranial solid tumor in infants, arising from developmentally stalled neural crest-derived cells. Driving tumor differentiation is a promising therapeutic approach for this ...